QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
The authors evaluated the effect of polymer composition on the drug-release profile and the effect of storage conditions on dissolution characteristics.
Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.
The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.
The pharmaceutical industry must understand its responsibilities to improve the safety of chemicals as defined by the REACH initiative.
Ongoing and emerging cyber-risks to legacy operational technology systems in bio/pharmaceutical manufacturing must be addressed.
Consider how to apply ALCOA+ to a building management system in non-clinical laboratories.
Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.
This review article explains how self-emulsifying drug delivery systems can increase the solubility and bioavailability of poorly soluble drug.
Change management is central to the evolution of quality control laboratories, but what factors can maximize patient outcomes?
BioSpectra Launches Class 6 Manufacturing Suite for Sterile filtered, GMP bulk Solutions, utilizing sterile, SUT packaging. First product launch: 5M NaCl solution made with WFI and multi-compendial salt.
Despite the market challenges caused by COVID-19, M&A activity in the life sciences sector is recovering well.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
Webinar Date/Time: Mon, Nov 18, 2024 11:00 AM EST
The degree of formality in a risk management process should be customized to the organization’s particular needs and the risks involved.
FDA’s final CMC guidance sets expectations for manufacturing and quality for human gene therapy INDs. This article reviews existing analytical applications, focusing on viral vector characterization of impurities.
An environmental risk assessment (ERA) is now required for all new pharmaceutical product marketing authorisation applications. The author outlines the steps to this procedure.
What do you need to ask during the vetting and selection process to ensure your clinical or commercial program won’t be derailed by a quality-related problem?
In this application note, we pair Simple Plex Assays on Ella with Cygnus 3G CHO antibodies for superior sensitivity and data reproducibility throughout bioproduction.
The 2D Data Matrix barcode is a familiar sight for most pharmaceutical manufacturers as printing is implemented to meet certain regulations.
Leveraging real-time MRI guidance for intracranial gene therapy administration potentially improves efficacy and outcomes.
Digital transformation allows for smarter and connected biomanufacturing operations.
Experts in solid dosage technology, offering electrostatic spray dryers, fluid bed systems, and other process solutions used daily to help the pharmaceutical, nutraceutical, food, fine chemical, and biopharmaceutical industries.
This paper explores the relationship between investing in pharmaceutical manufacturing risk reduction and meeting business objectives.
The manufacture of high potency active pharmaceutical ingredients (HPAPIs) is on the rise with R&D projects showing a continuing interest in these products.
A phase-appropriate analytical development strategy is crucial, especially for complex (formulated) drug substances.